M. S. Berger - Concepedia

Author

M. S. Berger

University of Pennsylvania

Also Known As

Berger M., M Berger, M S Berger, M. BERGER, M. Berger, M. S. Berger, M.S. Berger, MS Berger

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

University of Pennsylvania Georgetown University GlaxoSmithKline (United States)University of Washington Research Network (United States)

About

M. S. Berger is an author at University of Pennsylvania specializing in medicine, cancer research, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	19	1.1K
2	Health Sciences	4	4	111
3	Biochemistry	2	2	33
4	Cell Biology	2	2	110
5	Natural Sciences	1	1	13

M. S. Berger

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Selective Ablation of Acute Myeloid Leukemia Using Antibody-Targeted Chemotherapy: A Phase I Study of an Anti-CD33 Calicheamicin Immunoconjugate Eric L. Sievers, F R Appelbaum, Ricardo Spielberger, Blood	1999	456
Selective Ablation of Acute Myeloid Leukemia Using Antibody-Targeted Chemotherapy: A Phase I Study of an Anti-CD33 Calicheamicin Immunoconjugate Eric L. Sievers, Frederick R. Appelbaum, Ricardo Spielberger, Blood	1999	437
Characterization of A1, a novel hemopoietic-specific early-response gene with sequence similarity to <i>bcl-2</i> . Elaine Y. Lin, Amos Orlofsky, M. S. Berger, The Journal of Immunology	1993	336
Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin) M. A. Boogaerts, Elihu H. Estey, Chatchada Karanes, Leukemia Hematological MalignancyOncologyMixed-phenotype Acute LeukemiaAcute Myeloid LeukemiaMalignant Blood Disorder	2002	221
Case‐control study on stomach cancer in Germany Heiner Boeing, Rainer Frentzel‐Beyme, M. S. Berger, International Journal of Cancer	1991	187
Evaluation of epidermal growth factor receptors in bladder tumours M. S. Berger, C. Greenfield, WJ Gullick, British Journal of Cancer Urological ResearchUrologyGenitourinary CancerBladder TumoursMedicine	1987	166
A phase II, open-label, multicenter study of GW572016 in patients with trastuzumab-refractory metastatic breast cancer Kimberly Blackwell, Eli Kaplan, Sandra Franco, Journal of Clinical Oncology Tumor BiologyBreast OncologyPhase IiMedicineCancer Management	2004	90
Novel expression pattern of a new member of the MIP-1 family of cytokine-like genes. Amos Orlofsky, M. S. Berger, Michael B. Prystowsky Cell Regulation ImmunologyPathologyInflammationProtein ExpressionSignaling Pathway	1991	78
A phase II, randomized trial using the small molecule tyrosine kinase inhibitor lapatinib as a first-line treatment in patients with FISH positive advanced or metastatic breast cancer Henry Gómez, Miguel A. Chavez, Dinesh Chandra Doval, Journal of Clinical Oncology Metastatic Breast CancerOncologyPhase IiBreast OncologyMedicine	2005	72
The influence of gender on the outcome of arterial procedures in the lower extremity M Enzler, Monica Ruoss, Burkhardt Seifert, European Journal of Vascular and Endovascular Surgery Gender StudiesArterial ReconstructionsLower Limb TraumaVascular SurgeryUpper Extremity	1996	71

Page 1